611 related articles for article (PubMed ID: 35995341)
21. STATs signaling pathways in dendritic cells: As potential therapeutic targets?
Sohrabi S; Masoumi J; Naseri B; Ghorbaninezhad F; Alipour S; Kazemi T; Ahmadian Heris J; Aghebati Maleki L; Basirjafar P; Zandvakili R; Doustvandi MA; Baradaran B
Int Rev Immunol; 2024 May; 43(3):138-159. PubMed ID: 37886903
[TBL] [Abstract][Full Text] [Related]
22. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
[TBL] [Abstract][Full Text] [Related]
23. Targeting STAT proteins via computational analysis in colorectal cancer.
Dariya B; Muppala S; Srivani G; Momin S; Alam A; Saddala MS
Mol Cell Biochem; 2021 Jan; 476(1):165-174. PubMed ID: 32840738
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
Haura EB; Turkson J; Jove R
Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
[TBL] [Abstract][Full Text] [Related]
25. Genomic distribution of signal transducer and activator of transcription (STAT) family in colorectal cancer.
Hu Y; Shen Y; Zhao Y; Tang Y; Liu C; Gu Y; Yang T; Shen Y
Hum Cell; 2023 Jan; 36(1):286-295. PubMed ID: 36284066
[TBL] [Abstract][Full Text] [Related]
26. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
[TBL] [Abstract][Full Text] [Related]
27. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
29. MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.
Liu C; Xing H; Guo C; Yang Z; Wang Y; Wang Y
Cell Cycle; 2019 Sep; 18(18):2215-2227. PubMed ID: 31286834
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.
Slattery ML; Lundgreen A; Hines LM; Torres-Mejia G; Wolff RK; Stern MC; John EM
Breast Cancer Res Treat; 2014 Aug; 147(1):145-58. PubMed ID: 25104439
[TBL] [Abstract][Full Text] [Related]
31. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
Front Genet; 2023; 14():1120500. PubMed ID: 36968603
[No Abstract] [Full Text] [Related]
32. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells.
Dumler I; Kopmann A; Wagner K; Mayboroda OA; Jerke U; Dietz R; Haller H; Gulba DC
J Biol Chem; 1999 Aug; 274(34):24059-65. PubMed ID: 10446176
[TBL] [Abstract][Full Text] [Related]
33. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
34. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360879
[TBL] [Abstract][Full Text] [Related]
36. Signaling pathways governing breast cancer stem cells behavior.
Song K; Farzaneh M
Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
[TBL] [Abstract][Full Text] [Related]
37. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.
Segatto I; Berton S; Sonego M; Massarut S; Perin T; Piccoli E; Colombatti A; Vecchione A; Baldassarre G; Belletti B
Oncotarget; 2014 Aug; 5(15):6267-79. PubMed ID: 25026286
[TBL] [Abstract][Full Text] [Related]
38. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.
Loh CY; Arya A; Naema AF; Wong WF; Sethi G; Looi CY
Front Oncol; 2019; 9():48. PubMed ID: 30847297
[TBL] [Abstract][Full Text] [Related]
39. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation.
Tuli HS; Sak K; Iqubal A; Garg VK; Varol M; Sharma U; Chauhan A; Yerer MB; Dhama K; Jain M; Jain A
Mol Biol Rep; 2022 Sep; 49(9):8987-8999. PubMed ID: 35474053
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
